汕头大学医学院学报2024，Vol.37Issue(3)：147-151,5.DOI:10.13401/j.cnki.jsumc.2024.03.004
急性ST段抬高型心肌梗死患者急诊经皮冠状动脉介入治疗后发生对比剂肾病相关因素分析
Analysis of factors associated with the occurrence of contrast induced nephropathy after emergency percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction
摘要
Abstract
Objective:To investigate the factors associated with the occurrence of contrast induced nephropathy(CIN)after emergency percutaneous coronary intervention(PCI)in patients with ST-segment elevation myocardial infarction(STEMI).Methods:905 STEMI patients who underwent emergency PCI at the First Affiliated Hospital of Shantou University Medical College from January 2019 to December 2021 were retrospectively selected as the study subjects,and the patients were divided into the CIN group(n=54)and the non-CIN group(n=851)according to whether CIN occurred after PCI.Logistic regression was used to analyze the factors associated with the occurrence of CIN,and the area under curve(AUC)of the receiver operating characteristic(ROC)of the subjects was used to evaluate the predictive value of the associated factors for CIN.Results:The incidence of CIN after emergency PCI in STEMI patients was 6.0%(54/905).Multivariate logistic regression analysis showed that age(OR=1.043,95%CI:1.013-1.073,P=0.004),heart failure(OR=2.550,95%CI:1.413-4.600,P=0.002),blood uric acid(OR=1.003,95%CI:1.000-1.005,P=0.020)were associated with the occurrence of CIN after emergency PCI in STEMI patients.ROC curve analysis showed that the AUC(95%CI)for age and heart failure were 0.681(0.615,0.747)and 0.643(0.564,0.722),respectively.Conclusion:Age,heart failure,and blood uric acid may be correlates of the occurrence of CIN after emergency PCI in patients with STEMI,with age and heart failure having some predictive value for the occurrence of CIN.关键词
急性ST段抬高型心肌梗死/对比剂肾病/经皮冠状动脉介入治疗Key words
ST-segment elevation myocardial infarction/contrast induced nephropathy/percutaneous coronary intervention分类
医药卫生引用本文复制引用
邱少彬,黄贤生,林隆,陈淑英..急性ST段抬高型心肌梗死患者急诊经皮冠状动脉介入治疗后发生对比剂肾病相关因素分析[J].汕头大学医学院学报,2024,37(3):147-151,5.基金项目
汕头市医疗卫生科技计划项目(211115116494260) （211115116494260）
